Biology

Deck: 
The international collaboration between Regulus Therapeutics and Samsung Medical Center aims to develop novel therapies for brain cancer.

The following is a press release from Regulus Therapeutics announcing the microRNA therapeutic effort in brain cancer.   

Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer

-Regulus, Accelerate Brain Cancer Cure (ABC2) and Samsung Medical Center to Advance microRNA Therapeutics for Glioblastoma -

Main Image Credit: 
Dr. Harley Kornblum, UCLA

This article is reprinted with permission from its author, Kim Irwin, UCLA Broad Stem Cell Research Center.  The article features researcher Dr. Harley Kornblum, a speaker at Accelerate Brain Cancer Cure's Annual Scientific Meeting in 2009.

Researchers with UCLA’s Jonsson Comprehensive Cancer Center have developed and used a high-throughput molecular screening approach that identifies and characterizes chemical compounds that can target the stem cells that are responsible for creating deadly brain tumors.

Deck: 
ABC2 Is Lead Non-Profit Partner

Video Thumbnail: 

Dr. Paul Mischel discusses how molecular medicine is opening up new ways to treat and diagnose brain cancer.

Accelerate Brain Cancer Cure recently funded Dr. Karen Aboody, a pioneering stem cell researcher at the City of Hope Medical Center in Duarte, California. 

She is working on a revolutionary new cancer treatment for the very worst brain tumors called glioblastomas (GBM).  These types of tumors are so invasive that until now there's been no way to get large enough amounts of chemotherapy through the blood-brain barrier. 

A University of Alabama at Birmingham study has identified a gene deletion in nearly 25 percent of all glioblastoma cases that is believed to be responsible for poor patient outcomes. The discovery could lead to better diagnosis and targeted treatments with drugs that are currently available.

Subscribe to RSS - Biology
Share |

Join us in our fight for a cure!